CM

Craig Mello

Co-Founder, Nobel Laureate

Phio Pharmaceuticals

Therapeutic Areas

Phio Pharmaceuticals Pipeline

DrugIndicationPhase
PH-762Cutaneous Squamous Cell Carcinoma (Stages I, II, IV), Stage IV Melanoma, Stage IV Merkel Cell CarcinomaPhase 1b
PH-894Stage IV Melanoma, Head and Neck Squamous Cell Carcinoma, Hepatocellular Carcinoma, HPV-related cSCC, Cervical Cancer, Prostate CancerPreclinical
PH-231Not Specified (Melanin production-related)Discovery